Table 2.
Treatment modality | n | Maximal diameter of the largest lesion (cm) | Treatment frequency, range | Median (range) treatment duration (months)a |
Median (range) time to the first clinical improvement (months)a | Response rates, %, n/N | Adverse events (number of patients) |
---|---|---|---|---|---|---|---|
STS | |||||||
Topical | 48 | 13 | Twice a week to three times a day | 3.9 (0.3–24) | 4.0 (0.5–11) | Complete, 19, 9/48 | Transient pruritus (1), recurrence (1), skin irritation (2), zinc ointment allergy (1) |
Partial, 63, 30/48 | |||||||
None, 6, 3/48 | |||||||
Unknown, 13, 6/48 | |||||||
Intralesional | 53 | 65 | Single session to once a month | 1.0 (0.5–21) | 1.0 (0.25–4) | Complete, 36, 19/53 | Infection (5), injection pain (6b), blistering (1), skin discoloration (N/R) |
Partial, 38, 20/53 | |||||||
None, 25, 13/53 | |||||||
Unknown, 2, 1/53 | |||||||
Laser | |||||||
CO2 | 18 | 2.0 | One to three sessions | N/Ac | N/Ac | Complete, 57, 12/21 | Infection (2), recurrence (2), scaring or hyperkeratosis (10), hypopigmentation (2), itching or burning (2) |
Er:YAG | 1 | < 2.0 | Partial, 14, 3/21 | ||||
Diode | 1 | N/R | Unknown, 29, 6/21d | ||||
Picosecond + CO2 | 1 | N/R | |||||
ESWL | 11 | < 20.0 | Single session to twice a month | 2.25 (1–2.25) | N/Ac | Complete, 9, 1/11 | Transient fever (1) |
Partial, 55, 6/11 | |||||||
None, 27, 3/11 | |||||||
Unknown, 9, 1/11 | |||||||
Combined | |||||||
ESWL + intralesional STS | 1 | 5.0 | Once a week | 5.5 | N/R | Partial, 100, 1/1 | Crater-like defects (N/R) |
Picosecond + topical STS | 2 | 5.0 | Twice a week to twice a month | 6.0 | N/R | Partial, 100, 2/2 | None |
Er:YAG erbium-doped yttrium aluminium garnet, ESWL extracorporeal shockwave lithotripsy, N/A not applicable, N/R not reported, STS sodium thiosulfate
aMissing data were managed by available case analysis and mean imputation was used when a mean was known for a variable of interest but exact values were not reported for individual cases from a single study
bOlesen et al. [17] also reported injection pain, however, without an exact number of cases experiencing it
cA group of patients was too small
dBottomley et al. [13] reported outcomes as for particular lesions instead of describing overall response in each patient